Both, its ability to form DNA enzyme adducts (5-aza-dC/DNMT) inhibiting cell cycle progression and also leading to DSB as well as its function as de novo methyltransferase inhibitor (DNMTi) [43] are thought to contribute to these anti-cancer effects. This evidence concerns the gene DNMT1 and cancer.